BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 25887999)

  • 1. SULF2 overexpression positively regulates tumorigenicity of human prostate cancer cells.
    Vicente CM; Lima MA; Nader HB; Toma L
    J Exp Clin Cancer Res; 2015 Mar; 34(1):25. PubMed ID: 25887999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced tumorigenic potential of colorectal cancer cells by extracellular sulfatases.
    Vicente CM; Lima MA; Yates EA; Nader HB; Toma L
    Mol Cancer Res; 2015 Mar; 13(3):510-23. PubMed ID: 25477293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The SULFs, extracellular sulfatases for heparan sulfate, promote the migration of corneal epithelial cells during wound repair.
    Maltseva I; Chan M; Kalus I; Dierks T; Rosen SD
    PLoS One; 2013; 8(8):e69642. PubMed ID: 23950901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Upregulation of long non-coding RNA PlncRNA-1 promotes proliferation and induces epithelial-mesenchymal transition in prostate cancer.
    Jin Y; Cui Z; Li X; Jin X; Peng J
    Oncotarget; 2017 Apr; 8(16):26090-26099. PubMed ID: 28212533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SULFs in human neoplasia: implication as progression and prognosis factors.
    Bret C; Moreaux J; Schved JF; Hose D; Klein B
    J Transl Med; 2011 May; 9():72. PubMed ID: 21599997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sulf-2, a heparan sulfate endosulfatase, promotes human lung carcinogenesis.
    Lemjabbar-Alaoui H; van Zante A; Singer MS; Xue Q; Wang YQ; Tsay D; He B; Jablons DM; Rosen SD
    Oncogene; 2010 Feb; 29(5):635-46. PubMed ID: 19855436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene trap disruption of the mouse heparan sulfate 6-O-endosulfatase gene, Sulf2.
    Lum DH; Tan J; Rosen SD; Werb Z
    Mol Cell Biol; 2007 Jan; 27(2):678-88. PubMed ID: 17116694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sulfatase-2 promotes the growth and metastasis of colorectal cancer by activating Akt and Erk1/2 pathways.
    Tao Y; Han T; Zhang T; Sun C
    Biomed Pharmacother; 2017 May; 89():1370-1377. PubMed ID: 28320104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sulf1 and Sulf2 Differentially Modulate Heparan Sulfate Proteoglycan Sulfation during Postnatal Cerebellum Development: Evidence for Neuroprotective and Neurite Outgrowth Promoting Functions.
    Kalus I; Rohn S; Puvirajesinghe TM; Guimond SE; Eyckerman-Kölln PJ; Ten Dam G; van Kuppevelt TH; Turnbull JE; Dierks T
    PLoS One; 2015; 10(10):e0139853. PubMed ID: 26448642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sulfatase 2 promotes breast cancer progression through regulating some tumor-related factors.
    Zhu C; He L; Zhou X; Nie X; Gu Y
    Oncol Rep; 2016 Mar; 35(3):1318-28. PubMed ID: 26708018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HSULF-1 inhibits ERK and AKT signaling and decreases cell viability in vitro in human lung epithelial cells.
    Zhang H; Newman DR; Sannes PL
    Respir Res; 2012 Aug; 13(1):69. PubMed ID: 22873647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SULF2 methylation is prognostic for lung cancer survival and increases sensitivity to topoisomerase-I inhibitors via induction of ISG15.
    Tessema M; Yingling CM; Thomas CL; Klinge DM; Bernauer AM; Liu Y; Dacic S; Siegfried JM; Dahlberg SE; Schiller JH; Belinsky SA
    Oncogene; 2012 Sep; 31(37):4107-16. PubMed ID: 22158045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of Tripartite Motif-Containing Proteactiin 11 (TRIM11) is Associated with the Progression of Human Prostate Cancer and is Downregulated by MicroRNA-5193.
    Pan Y; Zhang R; Chen H; Chen W; Wu K; Lv J
    Med Sci Monit; 2019 Jan; 25():98-106. PubMed ID: 30608062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Organ-specific sulfation patterns of heparan sulfate generated by extracellular sulfatases Sulf1 and Sulf2 in mice.
    Nagamine S; Tamba M; Ishimine H; Araki K; Shiomi K; Okada T; Ohto T; Kunita S; Takahashi S; Wismans RG; van Kuppevelt TH; Masu M; Keino-Masu K
    J Biol Chem; 2012 Mar; 287(12):9579-90. PubMed ID: 22298771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TRPM4 channel is involved in regulating epithelial to mesenchymal transition, migration, and invasion of prostate cancer cell lines.
    Sagredo AI; Sagredo EA; Pola V; Echeverría C; Andaur R; Michea L; Stutzin A; Simon F; Marcelain K; Armisén R
    J Cell Physiol; 2019 Mar; 234(3):2037-2050. PubMed ID: 30343491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypoxia regulates ANXA1 expression to support prostate cancer cell invasion and aggressiveness.
    Bizzarro V; Belvedere R; Migliaro V; Romano E; Parente L; Petrella A
    Cell Adh Migr; 2017 May; 11(3):247-260. PubMed ID: 27834582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Down-regulation of E-cadherin enhances prostate cancer chemoresistance via Notch signaling.
    Wang W; Wang L; Mizokami A; Shi J; Zou C; Dai J; Keller ET; Lu Y; Zhang J
    Chin J Cancer; 2017 Mar; 36(1):35. PubMed ID: 28356132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential expression of epithelial and mesenchymal proteins in a panel of prostate cancer cell lines.
    Murali AK; Norris JS
    J Urol; 2012 Aug; 188(2):632-8. PubMed ID: 22704442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Small interfering RNA-directed targeting of Toll-like receptor 4 inhibits human prostate cancer cell invasion, survival, and tumorigenicity.
    Hua D; Liu MY; Cheng ZD; Qin XJ; Zhang HM; Chen Y; Qin GJ; Liang G; Li JN; Han XF; Liu DX
    Mol Immunol; 2009 Sep; 46(15):2876-84. PubMed ID: 19643479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RNAi-mediated knockdown of pituitary tumor- transforming gene-1 (PTTG1) suppresses the proliferation and invasive potential of PC3 human prostate cancer cells.
    Huang SQ; Liao QJ; Wang XW; Xin DQ; Chen SX; Wu QJ; Ye G
    Braz J Med Biol Res; 2012 Nov; 45(11):995-1001. PubMed ID: 22872288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.